Ganymede
Cloud platform to capture, automate, and analyze lab data.
- 21-100 employees
- B2B
- Enterprise
- Biology
- SaaS
- Data Analysis
- Cloud Computing
- Science
- Palo Alto, CA
Jump to section
Company mission
To improve lives through software.
Our take
Ganymede bills itself as the world’s first Platform-as-a-Service (PaaS) for biotech software engineering. It delivers a cloud-based platform, allowing scientists to automatically capture data, connect their lab instruments, and ultimately automate many aspects of their lab operations. The platform is capable of servicing early-stage biotechs all the way up to large pharmaceutical manufacturers
The originality of this offering gives the company an obvious edge, and further encouragement comes in the form of strong investment and industry interest. In 2026, it was announced that Ganymede would be acquired by Apprentice.io, which will result in the formation of the first AI-native platform spanning R&D through commercial manufacturing.
Kirsty
Company Specialist at Welcome to the Jungle
Benefits
- Remote-first role and culture, with periodic reimbursed travel for the team to meet together
- Unlimited PTO & sick days
- Excellent health benefits (Medical, Dental & Vision), life, and disability insurance
- Family leave (Maternity, Paternity, Medical, Caregiver)
Funding (2 rounds)
Dec 2022
$12.8m
SERIES A
Mar 2022
$2.9m
SEED
Total funding: $15.7m
This company has top investors
Leadership
Nathan Clark
(CEO & Founder)Former Goldman Sachs Trader. Pivoted to Product Management, serving in the role at Fintech company Affirm.inc, then at Benchling - a cloud-based platform for biotechnology research and development.